NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] Postdoctoral opportunity AstraZeneca Sweden

From: Rekic, Dinko <dinko.rekic_at_astrazeneca.com>
Date: Tue, 13 Mar 2018 15:50:51 +0000

Dear Colleagues,

AstraZeneca Quantitative Clinical Pharmacology (QCP) is seeking a postdoctoral fellow for a 2 to 3-year term. The role will be based at our Gothenburg site in Sweden with a competitive salary on offer.

This project offers the unique opportunity to apply your quantitative skills to explore a wealth of clinical data and generate support of a new class of medicines to treat chronic kidney disease and possibly other chronic conditions.

Your objective is to explore the effects of endogenous antioxidants on clinical outcomes using clinical data from external, internal, and literature sources. You will work in an interdisciplinary environment with close collaboration with scientists from academia as well as the preclinical and clinical drug discovery and development arena.

A PhD in Pharmacometrics, Quantitative Clinical Pharmacology, Applied Mathematics, Statistics or a related field is required.

Apply through the link below or reach out to me directly If you want to know more.
https://astrazeneca.wd3.myworkdayjobs.com/Emerging-Talent/job/Sweden---Gothenburg/Post-Doc-Fellow---Oxidative-stress-and-diabetic-CKD-outcomes_R-023047-1

Kind regards
Dinko


Dinko Rekić, PhD
Assoc Princ Scientist, Clinical Pharmacometrician
_____________________________________________________________________________________________
AstraZeneca R&D Gothenburg
Quantitative Clinical Pharmacology | Early Clinical Development
SE 431 83 Mölndal, Sweden
T: +46 (0)31 7766 16 26
Mobile: + 46 (0) 703-781346
e-mail: dinko.rekic_at_astrazeneca.com<mailto:dinko.rekic_at_astrazeneca.com>



________________________________

Confidentiality Notice: This message is private and may contain confidential and proprietary information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this message is not permitted and may be unlawful.

Received on Tue Mar 13 2018 - 11:50:51 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com. Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.